enVVeno Medical Corporation
NASDAQ:NVNO
0.7587 (USD) • At close September 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.528 | 0.546 | 0.525 | 0.453 | 0.384 |
| Gross Profit
| -0.528 | -0.546 | -0.525 | -0.453 | -0.384 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 12.249 | 13.583 | 9.914 | 5.728 | 4.252 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 |
| SG&A
| 11.049 | 11.109 | 14.493 | 10.712 | 4.499 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 23.298 | 24.692 | 24.407 | 16.44 | 8.751 |
| Operating Income
| -23.826 | -25.238 | -24.932 | -16.893 | -9.135 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.007 | 1.722 | 0.263 | 0.365 | -0 |
| Income Before Tax
| -21.819 | -23.516 | -24.669 | -16.528 | -9.135 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 |
| Net Income
| -21.819 | -23.516 | -24.669 | -16.528 | -9.135 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.27 | -1.91 | -2.2 | -1.9 | -7.54 |
| EPS Diluted
| -1.27 | -1.91 | -2.2 | -1.9 | -7.54 |
| EBITDA
| -21.291 | -22.97 | -24.144 | -16.075 | -8.752 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 |